The EBIC Executive Committee signed an agreement with NeuroVive Pharmaceuticals AB to collaborate with regard to the organisation and conduct of an european multicenter clinical trial on NeuroSTAT©. The active ingredient of NeuroSTAT© is cyclosporine-A which is considered a promising neuroprotective agent with a number of putative mechanisms, including mitocondrial protection.